Highlights: Phase 3 COMP005 trial in participants with treatment resistant depression (TRD) 6-week top-line data on track for second quarter 2025 Phase 3 COMP006 in TRD is on track for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback